Dennis A. Gastineau, MD, FACP

Bleeding and thrombosis in cancer patients cause significant morbidity and are a leading cause of mortality well before the malignancy is directly life-threatening.

The diagnosis and therapy of thrombotic thrombocytopenic purpura (TTP) have advanced dramatically in the past 25 years, with increasing diagnostic awareness spurred on by the discovery of plasma exchange as an effective therapy.